[
  {
    "text": "\nVaccine operators must be adequately trained in OSHA's bloodborne pathogens standard (29 CFR 1910.1030) and receive additional training as needed. osha.gov/coronavirus This document does not have the force or effect of law and is in no way intended to operate as a mandate to the public. This document is intended only to provide clarity to the public.\n    ",
    "identifier": "spanish3512",
    "title": "Safety Tips for Keeping Workers Safe at COVID-19 Virus Vaccination Sites",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "id": "ConsejosdeSeguridadparaMantenerSegurosalosTrabajadoresenlosSitiosdeVacunacionContraelVirusCOVID-19#~#756925#~#www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "date-crawl": "2021-12-10 at 14:44:43",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "url-orig": "https://www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "source": "www.osha.gov",
      "date": "10/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nthe health effects of cash transfer programs in low- and middle-income countries is particularly relevant in the current global economic crisis caused by COVID-19, which is likely to last, because these poverty-alleviating interventions could help the most impoverished populations, Rasella concludes.\n    ",
    "identifier": "spanish4330",
    "title": "Social programs that transfer cash can reduce maternal mortality",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
      "id": "Losprogramassocialesquetransfierendineroenefectivopuedendisminuirlamortalidadmaterna-News-ISGLOBAL#~#8700#~#www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
      "date-crawl": "2021-06-22 at 06:46:12",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
      "url-orig": "https://www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
      "source": "www.isglobal.org",
      "date": "22/06/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\non the immune system due to disease or treatment. If the person answered YES to question 5: if the person has been recently vaccinated, at least 7 days must have passed since then for vaccination against covid-19 to be relevant. To be completed by the vaccination clinic: Covid-19 vaccine name: Dose 1 \u274f Dose 2 \u274f Dose 3 \u274f Batch/lot number: Vaccine administered in: Right arm \u274f Left arm \u274f Other, if applicable\n    ",
    "identifier": "swedish1333",
    "title": "Health declaration adult vaccination against COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#119078#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "date-crawl": "2021-10-13 at 21:51:29",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "source": "www.folkhalsomyndigheten.se",
      "date": "13/10/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nChronic liver or kidney failure.\n' Conditions involving immune system impairment due to disease or treatment.\nIf the person answered YES to question 5: if the person has been recently vaccinated, at least 7 days must have passed since then for vaccination against covid-19 to be relevant.\nThe following is completed by the vaccination clinic: Covid-19 vaccine name: Dose 1 ' \" Dose 2 ' \" Batch/lot number: The vaccine has been administered in: Right arm ' \" Left arm ' \" Any other location for administration: Any comments: Health care provider: Reception/unit: Name of vaccinator: Signature: PUBLIC HEALTH AUTHORITY,\n2021\n    ",
    "identifier": "swedish3091",
    "title": "Health declaration adult vaccination against COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#137945#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "date-crawl": "2021-07-01 at 19:01:11",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "source": "www.folkhalsomyndigheten.se",
      "date": "01/07/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nEMA published new safety updates for Comirnaty, COVID-19 Vaccine Janssen, COVID-19 Vaccine Moderna and Vaxzevria\nEMA updated the guidance on preparing risk management plans for COVID-19 vaccines\n    ",
    "identifier": "english2",
    "title": "COVID-19: latest updates | European Medicines Agency",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
      "id": "COVID-19:latestupdatesEuropeanMedicinesAgency#~#310304#~#www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
      "date-crawl": "2021-06-28 at 11:36:01",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
      "url-orig": "https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
      "source": "www.ema.europa.eu",
      "date": "28/06/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\n142 new cases of COVID-19 reported\n9,816 new tests for COVID-19 that reported results\n    ",
    "identifier": "english5",
    "title": "Coronavirus (COVID-19): daily data for Scotland - gov.scot",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
      "id": "CoronavirusCOVID-19:dailydataforScotland-gov.scot#~#48749#~#www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
      "date-crawl": "2021-04-26 at 20:22:35",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
      "url-orig": "https://www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
      "source": "www.gov.scot",
      "date": "26/04/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nThe year 2020 will go down in history as the first year of the outbreak of the SARS-CoV-2 virus (coronavirus). The Dutch government took measures to stop the spread of the coronavirus. It seems that other infectious diseases were also less prevalent as a result. For example, there was\ngone by infectious diseases. This is expressed in disability-adjusted life years (DALYs); also called the burden of disease. In 2020, the most healthy life years were lost in the Netherlands to COVID-19 (169,400 DALYs), legionella (6,300 DALYs) and severe pneumococcal disease (6,200 DALYs. This top three is different than previous years because of COVID-19. In 2019, they were: severe pneumococcal disease\n    ",
    "identifier": "dutch569",
    "title": "State of infectious diseases in the Netherlands, 2020",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
      "id": "StaatvaninfectieziekteninNederland,2020#~#7764#~#www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
      "date-crawl": "2021-12-13 at 19:10:10",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
      "url-orig": "https://www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
      "source": "www.rivm.nl",
      "date": "13/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nis vaccinated. This is especially true for whooping cough, mumps, meningococcal disease, pneumococcal disease and measles. This is most likely due to the measures introduced because of the SARS-CoV-2 coronavirus outbreak. Examples include hand washing, keeping your distance, the (temporary) closure of schools and daycare centers, the smaller number of people at gatherings, and the maximum number to be received\nThe coronavirus outbreak also affected the way RVP was implemented in 2020. Group vaccinations (for children aged 9 and older) were first postponed or converted to individual appointments. From July 1\n    ",
    "identifier": "dutch1133",
    "title": "Vaccination rate and annual report National Vaccination Program Netherlands 2020",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
      "id": "VaccinatiegraadenjaarverslagRijksvaccinatieprogrammaNederland2020RIVM#~#8516#~#www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
      "date-crawl": "2021-07-05 at 15:57:20",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
      "url-orig": "https://www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
      "source": "www.rivm.nl",
      "date": "05/07/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nCovid-19: resources for the workplace\n Provides an overview of what will continue to be relevant in the future. EU-OSHA Acting Director William Cockburn provides an overview of emerging risks, and other colleagues highlight the continuing pandemic and offer advice on returning to\n    ",
    "identifier": "danish6948",
    "title": "Highlights | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
      "id": "HojdepunkterSafetyandhealthatworkEU-OSHA#~#124011#~#osha.europa.eu/da/highlights",
      "date-crawl": "2021-12-14 at 07:14:23",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
      "url-orig": "https://osha.europa.eu/da/highlights",
      "source": "osha.europa.eu",
      "date": "14/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nWith the end of the COVID-19 pandemic, it looks like working from home will continue to be used. But what can we learn from the companies that have been using teleworking since before the pandemic about how to ensure\n    ",
    "identifier": "czech5265",
    "title": "Key messages | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#122694#~#osha.europa.eu/cs/highlights",
      "date-crawl": "2021-11-16 at 06:43:15",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "url-orig": "https://osha.europa.eu/cs/highlights",
      "source": "osha.europa.eu",
      "date": "16/11/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  },
  {
    "text": "\nCOVID-19, telework and occupational health and safety: what lessons have we learned?\nIn light of the huge increase in teleworking caused by the COVID-19 pandemic, with many employees continuing to work from home, the new report looks at the associated health and safety risks. It includes in-depth interviews with workers\n    ",
    "identifier": "czech5395",
    "title": "Key messages | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#123448#~#osha.europa.eu/cs/highlights",
      "date-crawl": "2021-11-28 at 06:59:15",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "url-orig": "https://osha.europa.eu/cs/highlights",
      "source": "osha.europa.eu",
      "date": "28/11/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "en"
    },
    "sentences": []
  }
]
